The German National Pandemic Cohort Network (NAPKON): rationale, study design and baseline characteristics
-
Published:2022-07-29
Issue:8
Volume:37
Page:849-870
-
ISSN:0393-2990
-
Container-title:European Journal of Epidemiology
-
language:en
-
Short-container-title:Eur J Epidemiol
Author:
Schons MaximilianORCID, Pilgram LisaORCID, Reese Jens-PeterORCID, Stecher MelanieORCID, Anton GabrieleORCID, Appel Katharina S.ORCID, Bahmer ThomasORCID, Bartschke AlexanderORCID, Bellinghausen CarlaORCID, Bernemann Inga, Brechtel MarkusORCID, Brinkmann FolkeORCID, Brünn Clara, Dhillon Christine, Fiessler Cornelia, Geisler RamsiaORCID, Hamelmann EckardORCID, Hansch Stefan, Hanses FrankORCID, Hanß Sabine, Herold SusanneORCID, Heyder Ralf, Hofmann Anna-LenaORCID, Hopff Sina MarieORCID, Horn AnnaORCID, Jakob CarolinORCID, Jiru-Hillmann SteffiORCID, Keil ThomasORCID, Khodamoradi YaschaORCID, Kohls MirjamORCID, Kraus Monika, Krefting DagmarORCID, Kunze Sonja, Kurth FlorianORCID, Lieb WolfgangORCID, Lippert Lena JohannaORCID, Lorbeer Roberto, Lorenz-Depiereux Bettina, Maetzler Corina, Miljukov OlgaORCID, Nauck MatthiasORCID, Pape DanielORCID, Püntmann ValentinaORCID, Reinke Lennart, Römmele Christoph, Rudolph StefanieORCID, Sass JulianORCID, Schäfer ChristianORCID, Schaller JensORCID, Schattschneider Mario, Scheer ChristianORCID, Scherer MargareteORCID, Schmidt SeinORCID, Schmidt JuliaORCID, Seibel Kristina, Stahl Dana, Steinbeis FridolinORCID, Störk StefanORCID, Tauchert MaikeORCID, Tebbe Johannes JosefORCID, Thibeault CharlotteORCID, Toepfner NicoleORCID, Ungethüm Kathrin, Vadasz IstvanORCID, Valentin Heike, Wiedmann SilkeORCID, Zoller ThomasORCID, Nagel EikeORCID, Krawczak MichaelORCID, von Kalle ChristofORCID, Illig ThomasORCID, Schreiber Stefan, Witzenrath Martin, Heuschmann PeterORCID, Vehreschild Jörg Janne,
Abstract
AbstractThe German government initiated the Network University Medicine (NUM) in early 2020 to improve national research activities on the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) pandemic. To this end, 36 German Academic Medical Centers started to collaborate on 13 projects, with the largest being the National Pandemic Cohort Network (NAPKON). The NAPKON’s goal is creating the most comprehensive Coronavirus Disease 2019 (COVID-19) cohort in Germany. Within NAPKON, adult and pediatric patients are observed in three complementary cohort platforms (Cross-Sectoral, High-Resolution and Population-Based) from the initial infection until up to three years of follow-up. Study procedures comprise comprehensive clinical and imaging diagnostics, quality-of-life assessment, patient-reported outcomes and biosampling. The three cohort platforms build on four infrastructure core units (Interaction, Biosampling, Epidemiology, and Integration) and collaborations with NUM projects. Key components of the data capture, regulatory, and data privacy are based on the German Centre for Cardiovascular Research. By April 01, 2022, 34 university and 40 non-university hospitals have enrolled 5298 patients with local data quality reviews performed on 4727 (89%). 47% were female, the median age was 52 (IQR 36–62-) and 50 pediatric cases were included. 44% of patients were hospitalized, 15% admitted to an intensive care unit, and 12% of patients deceased while enrolled. 8845 visits with biosampling in 4349 patients were conducted by April 03, 2022. In this overview article, we summarize NAPKON’s design, relevant milestones including first study population characteristics, and outline the potential of NAPKON for German and international research activities.Trial registrationhttps://clinicaltrials.gov/ct2/show/NCT04768998.https://clinicaltrials.gov/ct2/show/NCT04747366.https://clinicaltrials.gov/ct2/show/NCT04679584
Funder
Bundesministerium für Bildung und Forschung Bayerisches Staatsministerium für Wissenschaft, Forschung und Kunst Deutsches Zentrum für Infektionsforschung Deutsche Forschungsgemeinschaft Bundesland Schleswig Holstein Universitätsklinikum Köln
Publisher
Springer Science and Business Media LLC
Reference59 articles.
1. Bchetnia M, Girard C, Duchaine C, Laprise C. The outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): a review of the current global status. J Infect Public Health. 2020;13:1601–10. 2. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet (Elsevier). 2020;395:497–506. 3. World Health Organization. Timeline: WHO’s COVID-19 response [Internet]. 2021 [cited 2021 Jul 18]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/interactive-timeline 4. Elisabeth E. Cameron, Jennifer B. Nuzzo, Jessica A. Bell, et al. Global Health Security Index 2019 [Internet]. 2019. Available from: https://www.ghsindex.org/report-model/ 5. WHO. WHO Coronavirus (COVID-19) Dashboard April 01 2022 [Internet]. 2022 [cited 2022 Apr 20]. Available from: https://web.archive.org/web/20220401050337/https://covid19.who.int/
Cited by
34 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|